Lawsuit Filed Challenging Proposed Sale of Varian to Agilent

According to a law firm, the proposed sale price of $52 for each share of Varian stock "appears unfair given that Varian shares traded close to $70 per share in 2008."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.